June 6, 2019 by C. Scott McMillin

If the dose is in fact subtherapeutic, then what causes the effects so enthusiastically reported by the user?


In the News: Magical Mushrooms

May 27, 2019 by C. Scott McMillin

Will society benefit from greater access to this drug? Are there potential problems we haven’t anticipated?


LSD Science Update

March 18, 2019 by C. Scott McMillin

The relative importance of set and setting suggests that the environment in an LSD experience should be carefully controlled.

Topics: ,

LSD in the UK

March 4, 2019 by C. Scott McMillin

I recall several cases admitted to the inpatient psych ward at one hospital where I worked in Boston, usually with severe psychotic symptoms.



July 30, 2018 by C. Scott McMillin

My concern is that these same hallucinogens have a pronounced tendency to escape the research environment and find their way out into the streets

Topics: , ,


July 28, 2016 by C. Scott McMillin

It’s the sort of evidence that convinced authorities to greatly expand access to opioids for chronic pain patients.

Topics: , ,

Acid Reflux… er, Redux

May 2, 2016 by C. Scott McMillin

Something about this class of drugs appears to turn some scientists into the equivalent of helpless fanboys.

Topics: ,

Synthetic Marijuana: A Brief Look

May 29, 2014 by C. Scott McMillin

Some of the adverse effects reported by K2 and Spice users are no doubt related to unidentified substances that adulterate the product.

Topics: , ,

Are Humans “Hard-Wired” for Getting High?

March 16, 2012 by C. Scott McMillin

I think the continuing popularity of substance use through the ages is because in practical terms, substances work.

Topics: , ,

Is LSD Going to Cure Alcoholism?

March 12, 2012 by C. Scott McMillin

The Norwegian study is part of an ongoing effort to restore the right of researchers to conduct studies involving therapeutic uses of LSD.

Topics: , , ,

Subscribe to RecoverySI via Email

New Content